Serveur d'exploration Tocilizumab - Checkpoint (Pmc)

Index « PmcKwd.i » - entrée « biologics »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
biologicals < biologics < biologics, desensitization  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]
Ident.Authors (with country if any)Title
000044 (2020) N. Ghalandari ; R. J. E. M. Dolhain ; J. M. W. Hazes ; C. L. E. Siezen ; J. W. Van Der Laan ; H. J. M. J. Crijns ; E. P. Van Puijenbroek ; C. J. Van Der WoudeThe pre‐ and post‐authorisation data published by the European medicines agency on the use of biologics during pregnancy and lactation
000065 (2020) José M. Carballido [Suisse] ; Camille Regairaz [Suisse] ; Celine Rauld [Suisse] ; Layla Raad [Suisse] ; Damien Picard [Suisse] ; Michael Kammüller [Suisse]The Emerging Jamboree of Transformative Therapies for Autoimmune Diseases
000128 (2020) Christos Koutsianas ; Konstantinos Thomas ; Dimitrios VassilopoulosReactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations
000450 (2019) Daniela Cici ; Addolorata Corrado ; Cinzia Rotondo ; Francesco P. CantatoreWnt Signaling and Biological Therapy in Rheumatoid Arthritis and Spondyloarthritis
000499 (2019) Deeti J. Pithadia ; Kelly A. Reynolds ; Erica B. Lee ; Wilson Liao ; Jashin J. WuTildrakizumab in the treatment of psoriasis: latest evidence and place in therapy
000533 (2019) Teresa Giani [Italie] ; Salvatore De Masi [Italie] ; Ilaria Maccora [Italie] ; Francesca Tirelli [Italie] ; Gabriele Simonini [Italie] ; Martina Falconi [Italie] ; Rolando Cimaz [Italie]The Influence of Overweight and Obesity on Treatment Response in Juvenile Idiopathic Arthritis
000587 (2019) Antoni Sicras-Mainar [Espagne] ; Ruth Navarro-Artieda [Espagne] ; José C. Armario-Hita [Espagne]Severe Atopic Dermatitis In Spain: A Real-Life Observational Study
000664 (2019) Kyosuke Hattori [Japon] ; Yuji Hirano [Japon] ; Yasuhide Kanayama [Japon] ; Nobunori Takahashi [Japon] ; Naoki Ishiguro [Japon] ; Toshihisa Kojima [Japon]Predictors of denosumab efficacy in treating osteoporosis in patients with rheumatoid arthritis: a Japanese multicenter study
000721 (2019) Cristiano Pagnini [Italie] ; Theresa T. Pizarro [États-Unis] ; Fabio Cominelli [États-Unis]Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor
000752 (2019) George E. Fragoulis [Grèce, Royaume-Uni] ; Elena Nikiphorou [Royaume-Uni] ; Jörg Larsen [Allemagne] ; Peter Korsten [Allemagne] ; Richard Conway [Irlande (pays)]Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment
000978 (2019) Samantha Alvarez-Madrazo [Royaume-Uni] ; Kimberley Kavanagh [Royaume-Uni] ; Stefan Siebert [Royaume-Uni] ; Yvonne Semple [Royaume-Uni] ; Brian Godman [Suède, Afrique du Sud] ; Alessandra Maciel Almeida [Brésil] ; Francisco De Assis Acurcio [Brésil] ; Marion Bennie [Royaume-Uni]Discontinuation, persistence and adherence to subcutaneous biologics delivered via a homecare route to Scottish adults with rheumatic diseases: a retrospective study
000A28 (2019) Der-Yuan Chen [Taïwan] ; Fun Yu [Taïwan] ; Li-Wen Tuan [Taïwan] ; Chao-Hsiun Tang [Taïwan]Comparison of Healthcare Utilization and Costs Between RA Patients Receiving Biological and Conventional Synthetic DMARDs: A Nationwide Population-Based Cohort Study in Taiwan
000A91 (2019) Rosalie MagroBiological therapies and their clinical impact in the treatment of systemic lupus erythematosus
000C08 (2018) Sachiyo Oishi [France] ; Daniel Wendling [France] ; Jean Sibilia [France] ; Chantal Job-Deslandre [France] ; Loic Guillevin [France] ; Jacques Benichou [France] ; René Marc Flipo [France] ; Carole Duquenne [France] ; Francis Guillemin [France] ; Alain Saraux [France]Treatment of active rheumatoid arthritis: comparison of patients younger vs older than 75 years (CORPUS cohort)
000C36 (2018) Fernando Kemta Lekpa [Cameroun] ; Xavier Chevalier [France]Refractory relapsing polychondritis: challenges and solutions
000C52 (2018) Konstantinos Thomas [Grèce] ; Argiro Lazarini [Grèce] ; Evripidis Kaltsonoudis [Grèce] ; Alexandros Drosos [Grèce] ; Ioannis Papalopoulos [Grèce] ; Prodromos Sidiropoulos [Grèce] ; Pelagia Katsimbri [Grèce] ; Dimitrios Boumpas [Grèce] ; Panagiota Tsatsani [Grèce] ; Sousana Gazi [Grèce] ; Kalliopi Fragkiadaki [Grèce] ; Maria Tektonidou [Grèce] ; Petros P. Sfikakis [Grèce] ; Lina Pantazi [Grèce] ; Kyriaki A. Boki [Grèce] ; Eleftheria P. Grika [Grèce] ; Panagiotis G. Vlachoyiannopoulos [Grèce] ; Konstantina Karagianni [Grèce] ; Lazaros I. Sakkas [Grèce] ; Theodoros Dimitroulas [Grèce] ; Alexandros Garyfallos [Grèce] ; Dimitrios Kassimos [Grèce] ; Gerasimos Evangelatos [Grèce] ; Alexios Iliopoulos [Grèce] ; Maria Areti [Grèce] ; Constantinos Georganas [Grèce] ; Konstantinos Melissaropoulos [Grèce] ; Panagiotis Georgiou [Grèce] ; Periklis Vounotrypidis [Grèce] ; Konstantinos Ntelis [Grèce] ; Clio P. Mavragani [Grèce] ; Ilias Bournazos [Grèce] ; Gikas Katsifis [Grèce] ; Christos Mavrommatis [Grèce] ; George D. Kitas [Grèce] ; Dimitrios Vassilopoulos [Grèce]Multicenter Cross-sectional Study of Patients with Rheumatoid Arthritis in Greece: Results from a cohort of 2.491 patients
000F33 (2015) Eve M D. Smith [Royaume-Uni] ; Helen E. Foster [Royaume-Uni] ; Michael W. Beresford [Royaume-Uni]The development and assessment of biological treatments for children
000F84 (2015) Aurelien Amiot ; Laurent Peyrin-BirouletCurrent, new and future biological agents on the horizon for the treatment of inflammatory bowel diseases
001006 (2014) Megan L. Krause ; Shreyasee Amin ; Ashima MakolUse of DMARDs and biologics during pregnancy and lactation in rheumatoid arthritis: what the rheumatologist needs to know
001163 (2011) Jamie Campbell [Royaume-Uni] ; David Lowe [Royaume-Uni] ; Matthew A. Sleeman [Royaume-Uni]Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis
001187 (2009) Troels HerlinTocilizumab: The evidence for its place in the treatment of juvenile idiopathic arthritis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Pmc/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/PmcKwd.i -k "biologics" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/PmcKwd.i  \
                -Sk "biologics" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Pmc
   |étape=   Checkpoint
   |type=    indexItem
   |index=    PmcKwd.i
   |clé=    biologics
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021